Hepatocyte transport of bile acids and organic anions in endotoxemic rats: impaired uptake and secretion

Gastroenterology
U BolderA F Hofmann

Abstract

In sepsis, intrahepatic cholestasis occurs frequently, suggesting impaired hepatocyte transport of bile acids and organic anions. The aim of the study was to define the magnitude, time course, and the site of impaired biliary secretion in a rat sepsis model. Maximal transport for two bile acids (cholyltaurine and chenodeoxycholyltaurine) and two organic anions (sulfobromophthalein and sulfolithocholyltaurine) was measured in isolated perfused livers at various times after lipopolysaccharide injection. Basolateral and canalicular liver plasma membrane vesicles were used to characterize the impairment in hepatocyte transport. Maximal hepatocyte transport was reduced for all compounds by 60%-81% compared with controls. Bile acid-independent bile flow was reduced by 51%. Impairment was maximal 12 hours after endotoxin injection and recovered thereafter. In basolateral plasma membrane vesicles, sodium-dependent transport for bile acids was reduced by 36%-47%. Sodium-independent transport of organic anions was reduced by 40%-55%. Adenosine triphosphate-stimulated transport was greatly decreased in canalicular vesicles prepared from endotoxemic animals for all four compounds probably because of a reduced number of transport molecules,...Continue Reading

Citations

Jan 13, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M ShiomiM Suematsu
Jul 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J M Crawford, J L Boyer
Mar 3, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D RostD Keppler
Oct 12, 2000·Indian Journal of Pediatrics·B S Tomar
Mar 1, 2012·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Martin SauerJan Stange
Apr 2, 2008·Current Gastroenterology Reports·Conrad R Cole, Thomas R Ziegler
Mar 26, 1998·Journal of Hepatology·M Müller, P L Jansen
Feb 26, 1999·American Journal of Surgery·T NishidaH Matsuda
Dec 6, 2001·European Journal of Pharmacology·M NadaiT Hasegawa
Mar 23, 2000·Journal of Hepatology·G A Kullak-UblickG Paumgartner
Sep 17, 1999·Journal of Hepatology·G A Kullak-Ublick
Jul 29, 1999·Journal of Hepatology·M TraunerJ L Boyer
Dec 21, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·G J HooiveldM Müller
Aug 2, 2003·Journal of the American College of Surgeons·Kimberly M BrownJin Wen Ding
May 24, 2003·Best Practice & Research. Clinical Gastroenterology·Richard K GilroyJohn L Gollan
Oct 13, 1998·Alimentary Pharmacology & Therapeutics·B T CooperT H Iqbal
Jan 9, 1999·Alimentary Pharmacology & Therapeutics·A F Goddard
Oct 26, 1999·Journal of Gastroenterology and Hepatology·M TraunerR E Stauber
Feb 24, 2001·Journal of Gastroenterology and Hepatology·D Kumar, R K Tandon
Jun 11, 2003·Journal of Gastroenterology and Hepatology·Makoto HojoHajime Takikawa
Sep 16, 2000·Pediatric Dermatology·P R BishopP H Parker
May 29, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T KawaguchiM Sata
Oct 22, 1998·The New England Journal of Medicine·M TraunerJ L Boyer
Jul 6, 2000·The Pediatric Infectious Disease Journal·R ShamirL Sirota
Jun 30, 1998·Current Opinion in Lipidology·M W Love, P A Dawson
Mar 6, 2007·Critical Care Medicine·Ludwig KramerUNKNOWN Austrian Epidemiologic Study on Intensive Care, ASDI Study Group
May 29, 2007·Shock·Marc G JeschkeDavid N Herndon
Jan 28, 2010·Pharmacological Reviews·Curtis D Klaassen, Lauren M Aleksunes
Apr 12, 2013·Critical Care : the Official Journal of the Critical Care Forum·Falk A GonnertAndreas Kortgen
Jun 29, 2007·Pediatric Research·Vincenzo ZanardoMario Plebani
Apr 22, 2010·Biomarkers in Medicine·G A Nagana Gowda
May 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ling-Jie MengK Sandy Pang
Oct 19, 2005·Intensive Care Medicine·Alexander StehrMartin Matejovic
Aug 2, 2007·Journal of Pediatric Gastroenterology and Nutrition·Clarivet TorresAlan Langnas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.